Eventually without material progressthey will once again run out of money ...The issue they will have is next time they will not be able to raise one penny from retail because of their track record of zero progress, underhand takeover and massive greed in salaries and renumeration. This would set the stage for this to go under or for sale. If Charm is right and they are missing pieces of the Ryplazim manufacturing puzzle then Ryplazim is done ..that leaves 4050 with no placebo trials completed. Looking pretty ugly.